Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide

被引:45
作者
Lendvai, N
Casadevall, A
Liang, ZL
Goldman, DL
Mukherjee, J
Zuckier, L
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA
[3] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[4] Yeshiva Univ Albert Einstein Coll Med, Dept Nucl Med, Bronx, NY 10461 USA
[5] W China Univ Med Sci, Dept Nucl Med, Chengdu 610041, Peoples R China
关键词
D O I
10.1086/515329
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cryptococcus neoformans is an encapsulated opportunistic fungus that can cause chronic infections accompanied by high tissue levels of capsular polysaccharide (CPS), CPS or its major component, glucuronoxylomannan (GXM), was administered to mice, and whole-body and tissue levels were measured. The role of monoclonal antibody (MAb), complement, and CD4 T cells in GXM clearance was also examined. These studies demonstrate that CPS is cleared from the blood within days but is retained in the body for weeks; that MAbs of all isotypes examined promote GXM clearance; that MAb-mediated GXM deposition in liver, but not in spleen, is Fc-dependent; that complement enhances IgM-mediated GXM sequestration in liver but not spleen; and that CD4 T cells are not necessary for serum GXM clearance. The results have important implications for the eventual use of MAbs in treatment of cryptococcosis.
引用
收藏
页码:1647 / 1659
页数:13
相关论文
共 72 条
[1]  
Abbas A.K., 1994, Cellular and molecular immunology
[2]  
[Anonymous], 1961, BLOOD OTHER BODY FLU
[3]   STUDIES ON INVIVO EFFECTS OF ANTIBODY - INTERACTION OF IGM ANTIBODY AND COMPLEMENT IN IMMUNE CLEARANCE AND DESTRUCTION OF ERYTHROCYTES IN MAN [J].
ATKINSON, JP ;
FRANK, MM .
JOURNAL OF CLINICAL INVESTIGATION, 1974, 54 (02) :339-348
[4]   RECEPTOR-MEDIATED CLEARANCE OF ASPERGILLUS GALACTOMANNAN [J].
BENNETT, JE ;
FRIEDMAN, MM ;
DUPONT, B .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (05) :1005-1010
[5]  
BENNETT JE, 1965, J IMMUNOL, V94, P916
[6]   STRUCTURE OF THE CAPSULAR POLYSACCHARIDE FROM CRYPTOCOCCUS-NEOFORMANS SEROTYPE-D [J].
BHATTACHARJEE, AK ;
KWONCHUNG, KJ ;
GLAUDEMANS, CPJ .
CARBOHYDRATE RESEARCH, 1979, 73 (AUG) :183-192
[7]   MONOCLONAL-ANTIBODY BASED ELISAS FOR CRYPTOCOCCAL POLYSACCHARIDE [J].
CASADEVALL, A ;
MUKHERJEE, J ;
SCHARFF, MD .
JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 154 (01) :27-35
[8]  
CASADEVALL A, 1992, J INFECT DIS, V65, P1086
[9]   CRYPTOCOCCAL ANTIGEN-DETECTION FROM THE URINE OF AIDS PATIENTS [J].
CHAPINROBERTSON, K ;
BECHTEL, C ;
WAYCOTT, S ;
KONTNICK, C ;
EDBERG, SC .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1993, 17 (03) :197-201
[10]   POLYSACCHARIDE ANTIGENS OF THE CAPSULE OF CRYPTOCOCCUS-NEOFORMANS [J].
CHERNIAK, R ;
SUNDSTROM, JB .
INFECTION AND IMMUNITY, 1994, 62 (05) :1507-1512